Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||
| May 2016 Volume 13 Number 5 | Advertisement | ||||||||||||||||||||||||||||||||||||
In this issue
|
| ||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| NEWS AND VIEWS | Top | ||||||||||||||||||||||||||||||||||||
| Coronary artery disease: Scavenger receptor class B1 — a target to reduce CHD risk? Philip J. Barter & Kerry-Anne Rye Published online: 07 April 2016 p249 | doi:10.1038/nrcardio.2016.50 A loss-of-function mutation in the gene encoding scavenger receptor class B member 1 (SRB1) has been identified. This mutation increases the risk of coronary heart disease (CHD) despite being associated with increased concentration of HDL cholesterol. Upregulation of SRB1 expression might be a novel therapeutic approach for reducing CHD risk. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Hypertension: Definition of pulmonary hypertension challenged? Adam Torbicki Published online: 24 March 2016 p250 | doi:10.1038/nrcardio.2016.44 The current definition of pulmonary hypertension (PH) is based on resting mean pulmonary arterial pressure (mPAP) ≥25 mmHg; however, analysis of long-term follow-up data now reveals increased mortality even with mPAP ≥19 mmHg. Do we need to modify the definition of PH, and what are the implications for clinical practice? Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Hypertension: When should we treat hypertension in patients with diabetes? Sverre E. Kjeldsen & Ingrid Os Published online: 07 April 2016 p252 | doi:10.1038/nrcardio.2016.49 Diabetes mellitus and hypertension are closely related, and guidelines have recommended aggressive treatment of hypertension in patients with diabetes. However, no single clinical trial is conclusive. An extensive review of the use of blood-pressure-lowering drugs in patients with diabetes supports treating blood pressure >140/90 mmHg, whereas reducing blood pressure in people with normal or high-normal blood pressure might have untoward effects. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Imaging: Focusing light on the vulnerable plaque Peter J. Psaltis & Stephen J. Nicholls p253 | doi:10.1038/nrcardio.2016.53 A new report has demonstrated the combined use of optical coherence tomography and molecular imaging within human coronary arteries. This combination provides a unique opportunity to look at plaque from a view not previously possible, opening the field for greater understanding of plaque biology in research and clinical practice. Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| REVIEWS | Top | ||||||||||||||||||||||||||||||||||||
| Acute coronary syndromes without coronary plaque rupture Siddak S. Kanwar, Gregg W. Stone, Mandeep Singh, Renu Virmani, Jeffrey Olin, Takashi Akasaka & Jagat Narula Published online: 25 February 2016 p257 | doi:10.1038/nrcardio.2016.19 A large number of acute coronary syndrome (ACS) events originate from plaques with an intact fibrous cap (IFC). In this Review, Kanwar et al. provide an overview of the latest advances in our understanding of plaque morphology in ACS with IFC, reviewing contemporary data from multimodality imaging. They also discuss whether the use of such imaging might result in more effective management of patients with ACS. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Noninvasive cardiac imaging in suspected acute coronary syndrome Pankaj Garg, S. Richard Underwood, Roxy Senior, John P. Greenwood & Sven Plein Published online: 25 February 2016 p266 | doi:10.1038/nrcardio.2016.18 Advanced noninvasive imaging techniques add diagnostic and prognostic value in patients with suspected acute coronary syndrome, complementing patient history, electrocardiogram, and cardiac biomarkers for timely identification or ruling out of acute coronary syndrome. In this Review, Garg and colleagues summarize the current guidelines and clinical use of the most common noninvasive imaging techniques, and provide an update on developments in noninvasive imaging. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Assessment, treatment, and prognostic implications of CAD in patients undergoing TAVI Edward Danson, Peter Hansen, Sayan Sen, Justin Davies, Ian Meredith & Ravinay Bhindi Published online: 11 February 2016 p276 | doi:10.1038/nrcardio.2016.9 Coronary artery disease (CAD) is common in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), but its clinical relevance is controversial. In this Review, Danson et al. summarize the methods of assessing CAD in TAVI populations, and the data on the safety and efficacy of percutaneous coronary intervention in patients undergoing TAVI. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Assessing quality-of-life outcomes in cardiovascular clinical research Daniel B. Mark Published online: 18 February 2016 p286 | doi:10.1038/nrcardio.2016.10 In this Review, Daniel Mark examines the use of health-related quality of life (QOL) as an outcome measure in clinical cardiovascular research. The main concepts, assumptions, tools, and methods used to assess QOL are discussed. Applied research into QOL outcomes in coronary artery disease, heart failure, and atrial fibrillation are also summarized, with an emphasis on experience from large, randomized clinical trials. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| *Journal Citation Reports, Thomson, 2015. Nature Reviews Cardiology was previously published as Nature Clinical Practice Cardiovascular Medicine. |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment
Keep a civil tongue.